| |
| |
|
| Insider
Information: |
Lebwohl David |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
93,073 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,276,566 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
93,073 |
|
|
| Total
Value |
$2,276,566 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intellia Therapeutics, Inc. |
NTLA |
|
2024-03-01 |
93,073 |
2021-08-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,701 |
93,073 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2024-01-03 |
4 |
S |
$29.46 |
$172,135 |
D/D |
(5,843) |
54,372 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,187 |
60,215 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,674 |
56,361 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,187 |
28,261 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,816 |
24,738 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2022-01-01 |
4 |
S |
$112.24 |
$117,964 |
D/D |
(1,051) |
10,922 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,187 |
11,973 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-11-05 |
4 |
AS |
$131.71 |
$318,535 |
D/D |
(2,400) |
8,714 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-11-05 |
4 |
OE |
$12.62 |
$30,288 |
D/D |
2,400 |
11,114 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-10-14 |
4 |
AS |
$126.92 |
$308,249 |
D/D |
(2,400) |
8,714 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-10-14 |
4 |
OE |
$12.62 |
$30,288 |
D/D |
2,400 |
11,114 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-09-24 |
4 |
OE |
$12.62 |
$99,988 |
D/D |
7,923 |
8,714 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-09-21 |
4 |
AS |
$149.81 |
$359,544 |
D/D |
(2,400) |
791 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-09-21 |
4 |
OE |
$12.62 |
$30,288 |
D/D |
2,400 |
3,191 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-08-30 |
4 |
AS |
$155.43 |
$379,300 |
D/D |
(2,400) |
791 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-08-30 |
4 |
OE |
$12.62 |
$30,288 |
D/D |
2,400 |
3,191 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-08-09 |
4 |
AS |
$164.05 |
$393,720 |
D/D |
(2,400) |
791 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Medical Officer |
• – – |
2021-08-09 |
4 |
OE |
$12.62 |
$30,288 |
D/D |
2,400 |
3,191 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
